Clinical trial
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
NCT00423059 · Yonsei University, Other · Completed
Key facts
| NCT number | NCT00423059 |
|---|---|
| Title | Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy |
| Official title | Histologic Changes of Fibrovascular Membrane Associated With Proliferative Diabetic Retinopathy After Intravitreal Bevacizumab (Avastin®) |
| Lead sponsor | Yonsei University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diabetic Retinopathy |
| Intervention type | Drug |
| Interventions | bevacizumab |
| Enrollment | 20 |
| Start date | Dec 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Jan 17, 2007 |
| Last update posted | Mar 13, 2007 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: